| Number |
Title |
Publication
|
| 02-46 |
A Phase II Study Of A Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus |
ASTRO Abstract
|
| 01-13 |
Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomized Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy Regimens |
PMID 18574157
|
| 97-16 |
CALGB 9781: A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, And Surgery) To Surgery Alone For Esophageal Cancer |
PMID 18309943
|
| 94-05 |
A Phase III Intergroup Randomized Comparison Of Combined Modality Therapy For Carcinoma Of The Esophagus: High Dose Vs. Conventional Dose Radiation Therapy |
PMID 11870157
|
| 92-07 |
A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus |
PMID 10699886
|
| 90-12 |
Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus |
PMID 10078631
|
| 85-01 |
Phase III trial of combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus |
PMID 10235156
|
